1. Home
  2. TOPP vs CDIO Comparison

TOPP vs CDIO Comparison

Compare TOPP & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • CDIO
  • Stock Information
  • Founded
  • TOPP 2014
  • CDIO 2017
  • Country
  • TOPP United States
  • CDIO United States
  • Employees
  • TOPP N/A
  • CDIO N/A
  • Industry
  • TOPP
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TOPP
  • CDIO Health Care
  • Exchange
  • TOPP NYSE
  • CDIO Nasdaq
  • Market Cap
  • TOPP 22.4M
  • CDIO 19.5M
  • IPO Year
  • TOPP 2025
  • CDIO N/A
  • Fundamental
  • Price
  • TOPP $1.22
  • CDIO $0.39
  • Analyst Decision
  • TOPP
  • CDIO Buy
  • Analyst Count
  • TOPP 0
  • CDIO 1
  • Target Price
  • TOPP N/A
  • CDIO $2.00
  • AVG Volume (30 Days)
  • TOPP 91.6K
  • CDIO 788.4K
  • Earning Date
  • TOPP 01-01-0001
  • CDIO 05-14-2025
  • Dividend Yield
  • TOPP N/A
  • CDIO N/A
  • EPS Growth
  • TOPP N/A
  • CDIO N/A
  • EPS
  • TOPP 0.01
  • CDIO N/A
  • Revenue
  • TOPP $16,039,513.00
  • CDIO $34,890.00
  • Revenue This Year
  • TOPP N/A
  • CDIO $1,434.82
  • Revenue Next Year
  • TOPP N/A
  • CDIO $4,661.91
  • P/E Ratio
  • TOPP $104.65
  • CDIO N/A
  • Revenue Growth
  • TOPP N/A
  • CDIO 104.45
  • 52 Week Low
  • TOPP $1.05
  • CDIO $0.19
  • 52 Week High
  • TOPP $4.50
  • CDIO $1.77
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • CDIO 49.37
  • Support Level
  • TOPP N/A
  • CDIO $0.30
  • Resistance Level
  • TOPP N/A
  • CDIO $0.43
  • Average True Range (ATR)
  • TOPP 0.00
  • CDIO 0.05
  • MACD
  • TOPP 0.00
  • CDIO 0.01
  • Stochastic Oscillator
  • TOPP 0.00
  • CDIO 74.32

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Share on Social Networks: